Key facts
- It has raised $25.7M; the latest was Early Stage VC ($25.7M) in Apr 2026.
- Notable investors include Norte Ventures, Airborne Ventures, DGF Investimentos, IC Ventures, Latitud.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Maggu
- ·The full record, as it builds
Funding rounds
No funding rounds for Maggu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maggu
Developer of an artificial intelligence platform intended for the optimization of pharmaceutical retail services. The company's platform utilizes machine learning algorithms to assist counter service teams during every stage of the customer interaction by locating the most appropriate medication and providing automated personalized product recommendations, enabling businesses in the healthcare sector to provide precise medical solutions to specific patient needs while simultaneously improving operational efficiency and driving measurable sales growth through enhanced service consistency.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2023
- Employees
- 38
- Website
- maggu.ai/
- Ownership
- Privately Held (backing)
Maggu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maggu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maggu in its N-PORT filings yet. We sweep new filings monthly.